Investigation on 100 patients aged over 50, treated at cardiology department of Thanh Nhan hospital from January to December 2001 showed that: Heart failure was common in cardiovascular diseases (14.6%). The incident of heart failure increased with age, more in females than in males. The common causes of heart failure were valvular diseases (37%), hypertension (31%), myocardial ischemia (17%)… The majority of patients with heart failure hospitalized were in severe situation (third degree: 51%, fourth degree: 10%). Besides diuretic and Digoxin, most patients must use the angiotensin converting enzyme (ACE) inhibitor, other used β blockers
Heart Failure ; Aged ; Diagnosis

Heart functions are not only blood pump but also endocrine, through discovery of diuretic peptids that helping excretion of sodium (natriuretic peptids) released by heart muscle. And very quickly, there was an explosion of studies about the values of these hormones in the diagnosis and management of some cardiovascular diseases, especially congestive heart failure (by nature there wasn’t any biochemical test) in the early 21st century
Hormones ; Heart Failure ; diagnosis ; heart

More than 50% of patients who are diagnosed with heart failure have preserved ejection fraction (HFpEF), and they have an equally poor prognosis when compared to patients with heart failure with reduced ejection fraction (HFrEF). However, a comprehensive understanding and awareness of heart failure with preserved ejection fraction is still limited and there are currently no optimized treatments to improve morbidity and mortality in these patients. This review summarizes the differences in the epidemiology, pathophysiology, diagnosis, and prognosis between HFpEF and HFrEF. We also review current management strategies of HFpEF patients according to evidence-based treatment guidelines.
Diagnosis ; Epidemiology ; Heart Failure* ; Heart Failure, Diastolic ; Humans ; Mortality ; Prognosis

No abstract available.
Diagnosis* ; Heart Failure* ; Heart Septal Defects, Ventricular ; Heart*

3 months after 2nd stage of myocard infarctus, 208 patients including 103 with heart failure and 105 with no heart failure (control), there is no difference in age and gender. Among risk factors, smoking and high uric acid level between two groups there is significant differences. ST heart rate is higher than control. There is no difference on systolic and diastolic blood pressure between 2 groups but on clinical symptoms, the difference is noted such as dyspnoea in effort, pneumatio rale, electro cardiogramme. Left ventricle function ultrasound has significant difference statistically
Myocardial Infarction ; Heart Failure, Congestive ; Patients ; diagnosis

No abstract available.
Diagnosis* ; Estrogens, Conjugated (USP)* ; Heart Failure*

Heart Failure ; diagnosis ; therapy ; Humans ; Phonocardiography ; methods

The study of 113 heart failure patients with rheumatic fever at Hai Phong Children Hospital from 1995 to 2001. Carditis encountered in rheumatic fever for the first time was 58%, however carditis in rheumatic fever since the second time was 100%. The valvular sequelea was only encountered in severe cases and the more the disease the more the valvular sequelea had, the common sequelea was mitral insuffisance (45.18%). 93.92% patients were out of heart failure. While the mortality rate was 3.54%. 100% patients were treated using anti inflammation and anti infection, so the parallel treatment: anti inflammation and anti infection were especially necessary
Heart Failure ; Diagnosis ; Therapeutics ; Rheumatic Fever ; Child

Heart Failure, Diastolic ; diagnosis ; prevention & control ; Humans

The prevalence of heart failure (HF) has been steadily increasing and it now creates an enormous social and economic burden. HF is a syndrome characterized by a high mortality rate, frequent hospitalization, a reduced quality of life, and a complex therapeutic regimen. In the last three decades, major progress in both the diagnosis and management of HF has taken place, and the pharmacologic and non-pharmacologic advances have led to a significant improvement in survival and symptoms in HF patients. After an accurate diagnosis, a proper HF management plan requires a multi-level team approach comprised of the correct combination of drug therapy, device therapy, and surgery, including heart transplantation. In this review, we focused on the pharmacologic and non-pharmacologic treatment strategies for HF with reduced ejection fraction. The goal was to develop treatment guidelines based on significant evidence derived from large clinical trials.
Diagnosis ; Drug Therapy ; Heart Failure* ; Heart Failure, Systolic ; Heart Transplantation ; Hospitalization ; Humans ; Mortality ; Prevalence ; Quality of Life